Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Oncogene|November 22, 2002
Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2Clotilde Billottet, Bassam Janji, Jean-Paul Thiery, et al.
Cancer Letters|November 3, 2015
miR-210 and hypoxic microvesicles: Two critical components of hypoxia involved in the regulation of killer cells functionMuhammad Zaeem Noman, Bassam Janji, Guy Berchem, et al.
Scientific Reports|November 4, 2024
Atypical chemokine receptor 2 expression is directly regulated by hypoxia inducible factor-1 alpha in cancer cells under hypoxiaAlice Benoit, Audrey Lequeux, Phillip Harter, et al.
Oncoimmunology|September 18, 2018
High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemiaMarina Wierz, Bassam Janji, Guy Berchem, et al.
Journal of Cellular Biochemistry|May 16, 2022
CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMTMalina Xiao, Caroline Duhem, Anwar Chammout, et al.
Cells|July 14, 2023
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer ImmunotherapyAlice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Critical Reviews in Immunology|June 19, 2014
Tumor plasticity interferes with anti-tumor immunitySalem Chouaib, Bassam Janji, Andres Tittarelli, et al.
Oncoimmunology|September 17, 2020
Firing up the cold tumors by targeting Vps34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
Chimia|October 29, 2020
The 'Holy Grail' in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning StrategyAndreas Schläpfer, Christian Auclair, Bassam Janji, et al.
Oncoimmunology|September 18, 2018
Driving Natural Killer cells toward the melanoma tumor battlefield: Autophagy as a valuable therapeutic targetMuhammad Zaeem Noman, Jerome Paggetti, Etienne Moussay, et al.
Pageof 10